More Data Shows High Efficacy for Pfizer, BioNTech Vaccine

Nov 18, 2020

This post has been update to fix an error regarding the group in which the severe cases occurred.

An analysis of updated data indicates the experimental SARS-CoV-2 vaccine from Pfizer and BioNTech has a 95 percent efficacy, the Wall Street Journal reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Featured White Papers

Performance of SARS-CoV-2 Assay in Extraction-free Method Compared to that of Conventional RNA Extraction using Automated Instrument

The Importance of Sample Pooling in COVID-19 Testing

The Importance of Limit of Detection in COVID-19 Tests

Automated RT-PCR Setup for COVID-19 Testing

Apr

22

Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr

23

Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function.

May

10

Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand.

May

12

Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

Menu